Skip to main content

Henry Schein (HSIC) Gets a Hold from Mizuho Securities

Tipranks - Wed Jan 21, 4:32AM CST

In a report released today, Steven Valiquette from Mizuho Securities maintained a Hold rating on Henry Schein, with a price target of $81.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Valiquette is a 2-star analyst with an average return of 0.2% and a 52.40% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as Cencora, Cardinal Health, and DENTSPLY SIRONA.

In addition to Mizuho Securities, Henry Schein also received a Hold from Leerink Partners’s Michael Cherny in a report issued on January 13. However, on January 16, Bank of America Securities maintained a Buy rating on Henry Schein (NASDAQ: HSIC).

Based on Henry Schein’s latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $3.34 billion and a net profit of $101 million. In comparison, last year the company earned a revenue of $3.17 billion and had a net profit of $99 million

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.